Hassan Kadhim Defines Decentralized Clinical Trials | ProofPilot
Interest in decentralized clinical trials (DCTs) is now full steam ahead – and so is the confusion....
Featured contributor to the SCRS initiative reducing redundant site training by 25%+
The Patient Perspective in Oncology Research Participation
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Don’t believe the hype. Most patient dropouts CANNOT be avoided. In my 23 years of clinical...
Choosing the right technology to engage clinical trial sites is crucial for study success. Two...
Table of Contents 📄 The Forecasting Problem No One Wants to Talk About 📄 What Data-Driven...
Over the past year, ProofPilot truly leveled up—we generated amazing customer experiences, joined...
Interest in decentralized clinical trials (DCTs) is now full steam ahead – and so is the confusion....
We know clinical trials are vital for developing new medicines, medical devices, and diagnostic...
I am old enough to remember the days before caller ID when poor souls would simply pick up every...
In Part 1 of this series on Reducing Risk in Decentralized Trials, we covered 7 key issues that...
Since 1999, I have been trying to crack the nut of how to scale physician referrals as a successful...
On a recent Diligent Pharma Webinar, Joseph Kim, Chief Strategy Officer of ProofPilot, covered 7...